Cell and Gene Therapy CDMO Market to reach US$ 18.6 billion by 2032
Prophecy Market Insights
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company.
Cell and Gene Therapy CDMO Market to reach US$ 18.6 billion by 2032; Rising Demand for CDMOs from Emerging Pharmaceutical Companies to Propel Industrial Progress
Cell and Gene Therapy plays an important role in today’s healthcare, to treat, and potentially cures diseases. Cell and Gene therapy CDMO are used for development of new modalities such as gene therapies, cell therapies, and innovative vaccines necessitates a significant investment in new manufacturing facilities for cell manipulation, viral vectors, nucleic acid and lipid-based formulations.
As CDMOs are able to flexibly alter their production lines to meet the rising demand of smaller and diverse projects, foster the growth of target market. Further, New partnerships with pharmaceutical and biotechnology companies have enabled CDMO players to fuel the rapid growth of capabilities and capacities by helping industries succeed in drug and vaccine production. Integration of clinical trial services is expected to become a new trend for CDMOs as they enter high-value, low-volume segments such as personalized medicine. Technological advancement in Cell and Gene Therapy has also driven the market's growth.
The report “Cell and Gene Therapy CDMO Market, By Service Area (Cell Therapy, Plasmid DNA, Viral Vector, and Others), By Indication (Cancer, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders), By Phase (Phase 1, Phase 2, Phase 3, Phase 4), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”
Key Highlights:
Analyst View:
Cell and gene therapy has become a complex field that requires a high level of expertise and robust manufacturing facilities. As Cell and Gene Therapy requires costly production and various manufacturing processes, outsourcing services to CDMOs is increasing. CDMOs aid in the formation of long-term partnerships that benefit the success of current products as well as the manufacturing of future products of key player’s pipeline along with business expansion. However, rising demand for outsourcing cell and gene therapy development and production due to a lack of manufacturing facilities and high costs is expected to boost the target market. Further, emerging pharmaceutical companies, which are also involved in research and development of cell and gene therapy, and have low funding in turn will opt for CDMO. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish positions in the market.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
Key Market Insights from the report:
Cell and Gene Therapy CDMO Market accounted for US$ 3.2 billion in 2022 and is estimated to be US$ 18.6 billion by 2032 and is anticipated to register a CAGR of 18.1%. The Cell and Gene Therapy CDMO Market is segmented based on Service Area, Indication, Phase and Region.
Recommended by LinkedIn
Competitive Landscape & their strategies of Cell and Gene Therapy CDMO Market:
The prominent players operating in the Cell and Gene Therapy CDMO Market includes, Catalent Pharma Solutions , Lonza , Recipharm , WuXi Advanced Therapies , Pfizer , Charles River Laboratories , Patheon , Almac Group , FUJIFILM Diosynth Biotechnologies , PCI Pharma Services , and others.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Emerging Players: Excellos , BioInno Bioscience Co., Ltd. , Porton Advanced │ Cell & Gene Therapy CDMO/CRO , Chanshow Biotechnology Inc , ROSLIN CELLS LIMITED , and Exothera .
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
To know more
Contact Us:
Sales
Prophecy Market Insights
Website- www.prophecymarketinsights.com